FDA reverses warning on hormone therapy products for menopause

The agency, in reversing its 2003 decision, says the treatments offer heart, brain, and bone health benefits.

November 10, 2025 Check out STAT+

Sponsored By

Ian Waldie/Getty Images FDA reverses decades-old warning on hormone therapy products for menopause FDA removes black box warning on hormone therapy, reflecting new science on menopause, heart health, and evolving views on women's care. By Theresa Gaffney and Chelsea Cirruzzo STAT+ | Is the White House's deal with pharma on GLP-1 drugs a game changer?  Whether the agreements with Eli Lilly and Novo Nordisk can make a big difference for patients depends on a host of factors. By Elaine Chen Canada loses measles elimination status — as does the entire Americas region The decision by the Pan American Health Organization, the regional office for the Americas for the WHO, reflects prolonged transmission of virus. By Helen Branswell Hans Pennink/AP STAT+ | How Children's Health Defense plans to cement its agenda beyond RFK Jr. Children's Health Defense is leveraging its ties to HHS to lock in legal and cultural shifts that could shape policy long after RFK Jr. leaves By Daniel Payne STAT+ | Fate of ACA subsidies still clouded after deal to reopen the government Democrats negotiated a future vote on Affordable Care Act tax credits in return for reopening the government, but there's no guarantee of passage. By John Wilkerson Opinion: It's time to fundamentally rethink how America pays for health care We must change the underlying valuation to reward cognitive health "care" services rather than high-tech "cure" services, doctor writes. By Daniel Plotkin CHARLY TRIBALLEAU/AFP via Getty Images At AHA meeting, CRISPR data gleamed but 'food as medicine' spoke to the now The American Heart Association meeting bristled with CRISPR-era possibility, but food and nutrition advice was still shown to have power. By Elizabeth Cooney

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser